Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PerceptiMed was a U.S. healthcare technology company focused on reducing medication dispensing errors in retail, long-term-care, and hospital pharmacy settings. The company developed computer-vision and automation products including identRx for pill identification, veriFill for prescription verification, and scripClip for will-call workflow management. In July 2021, PerceptiMed rebranded as InterLink AI to emphasize its use of artificial intelligence, machine learning, and data analytics in pharmacy operations. Its offerings were commercial-stage pharmacy technology products rather than therapeutic drug programs. InterLink AI later ceased operations, and its assets were acquired by Phoenix Pharmatech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PerceptiMed.